A Randomized Study of Amplimexon With Gemcitabine in Pancreatic Cancer

This study is ongoing, but not recruiting participants.

Study NCT00637247 Information provided by AmpliMed Corporation

First Received: March 10, 2008 Last Updated: May 13, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2010
Estimated Primary Completion Date:	April 2010 (Final data collection date for primary outcome measure)